Structure and binding properties of serum albumin in uremic patients at different periods of hemodialysis

Artificial Organs

Volumn 22, Issue 2, 1998, Pages 107-115

  Sarnatskaya, Veronika V ^a   Ivanov, Andrey I ^b   Nikolaev, Vladimir G ^a   Rotellar, Emillio ^c   Von Appen, Kai ^d   Haspar, M ^c   Maslenny, Vitaly N ^a   Klinkmann, Horst ^e  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b INSTITUTE OF BIOORGANIC CHEMISTRY   (Belarus)

^c Clinica Renal   (Spain)

^d UNIVERSITY OF MUNICH   (Germany)

^e Intl Faculty for Artificial Organs   (Italy)

Author keywords

Albumin; Differential scanning microcalorimetry; Flow microcalorimetry; Fluorescence; Hemodialysis; Ligand binding; Uremia

Indexed keywords

BINDING ENERGY; BODY FLUIDS; CALORIMETERS; DIAGNOSIS; HEMODIALYZERS; LIGANDS; MOLECULES; PATIENT TREATMENT; PROTEINS;

ALBUMIN; BINDING CAPACITIES; DIFFERENTIAL SCANNING MICROCALORIMETRY; FLOW MICROCALORIMETRY; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN SERUM ALBUMINS; LIGAND BINDING; SCANNING MICROCALORIMETRY; UREMIA;

DIALYSIS;

HUMAN SERUM ALBUMIN; LIGAND;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LIGAND BINDING; MALE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; TEMPERATURE DEPENDENCE; THERMOGRAPHY; UREMIA;

EID: 0031886291     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Niwa T, Takeda N, Tatematsu A, Maeda K. Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 1988;36:2264-7.
2. Mabuchi H, Nakahashi H. A major inhibitor of phenytoin binding to serum protein in uremia. Nephron 1988;48:310-4.
3. Sanaka T, Kawashima Y, Tanaka Y. Analysis of indoxyl sulfate and hippuric acid as representative protein-bound uremic toxins in patients with chronic renal failure on maintenance hemodialysis. J Jpn Soc Dial 1989;22:71-5.
4. Niwa T, Yazawa T, Kodama T, Uchara Y, Maeda K, Yamada K. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis. Nephron 1990;56:241-5.
5. Niwa T, Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 1994;124:96-104.
6. Vanholder R, Van Loo A, Dhondt AM, Glorieux G, De Smet R, Ringoir S. Second symposium on uraemic toxicity. Nephrol Dial Transplant 1995;10:414-8.
7. Sjoholm I, Kober A, Odar-Cederlof O, Borgaa O. Protein binding of drugs in uremic and normal serum: The role of endogenous binding inhibitors. Biochem Pharmacol 1976;25: 1205-13.
8. Bowmer CJ, Lindup WE. Decreased drug binding in uremia: Effect of indoxyl sulfate and other endogenous substances on the binding of drugs and dyes to human albumin. Biochem Pharmacol 1976;31:319-23.
9. Viani A, Rizzo G, Carai M, Pacifici GM. The effect of aging on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. Br J Clin Pharmacol 1992;33:299-304.
10. Vanholder R, De Smet R, Ringoir S. Factors influencing drug protein binding in patients with end stage renal failure. Eur J Clin Pharmacol 1993;44:319-23.
11. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The prediction value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 1990;15:458-82.
12. Rocco MV, Jordan JR, Burkart JM. The efficacy number as a predictor of morbidity and mortality in peritoneal dialysis patients. J Am Soc Nephrol 1993;4:1184-91.
13. Port FK, Harrington JT, Lafayette R, Brown RS, Levey AS, Steinman TL, Meyer K, Madias NE, Neyringer JR. Morbidity and mortality in dialysis patients. Kidney Int 1994;46:1728-37.
14. Vasileva R, Jakab M, Hasko F. Application of ion exchange chromatography for the production of human serum albumin. J Chromatogr 1981;216:279-84.
15. Mayer HR. Disk-electrophorese. Berlin: Walter der Gruyter & Co., 1963.
16. Nikolaev VG, Sarnatskaya VV, Ivanyuk AA, Yushko LA. Thermodynamic criteria for the removal of certain hepatic insufficiency markers from protein-containing solutions. In: Brunner G, Mito M, eds. Artificial liver support. Berlin: Springer Verlag, 1992;197-210.
17. Privalov PL, Potekhin SA. Scanning microcalorimetry in studying temperature-induced changes in proteins. Methods Enzymol 1986;131:4-51.
18. Burhstein EA, Vedenkina NS, Ivkova MN. Fluorescence and the location of tryptophan residues in protein molecules. Photochem Photobiol 1973;18:263.
19. Brunetti A, Prosen EJ, Goldberg RN. The enthalpy of reaction of tris(hydroxymethyl)aminomethane with hydrochloric acid. J Res Natl Bur Stand (US) 1973;77A:599-606.
20. Coassolo P, Sarrazin M, Sari JC, Briand C. Microcalorimetric studies on the binding of some benzodiazepin derivatives to human serum albumin. Biochem Pharmacol 1978;27:2787-92.
21. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971;31:87-96.
22. Duncombe WG. The colorimetric micro-determination of long-chain fatty acids. Biochem J 1963;88:7-10.
23. Shrake A, Finlayson JS, Ross PD. Thermal stability of human albumin measured by differential scanning calorimetry. I. Effects of caprylate and N-acetyltrypto-phanate. Vox Sang 1984; 47:7-18.
24. Shrake A, Ross PD. Biphasic denaturation of human albumin due to ligand redistribution during unfolding. J Biol Chem 1988;263:15392-9.
25. Brandts JF, Lin LN. Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochemistry 1990;29:6927-40.
26. Muccio DD, Waterhous DV, Fish F, Brouillette CG. Analysis of the two-state behavior of the thermal unfolding of serum retinol binding protein containing a single retinol ligand. Biochemistry 1992;31:5560-7.
27. Soler-Argilaga C, Infante R, Polonovski J. Demonstration of two pools of albumin-bound fatty acids. J Lipid Res 1975;16: 116-22.
28. Gumpen S, Hegg PO, Martens H. Thermal stability of fatty acid-serum albumin complexes studied by differential scanning calorimetry. Biochim Biophys Acta 1979;574:189-96.
29. Yamasaki M, Yano H, Aoki K. Differential scanning calorimetric studies of bovine serum albumin: I Effects of pH and ionic strength. Int J Biol Macromol 1990;12:263-8.
30. Ivkova MN, Vedenkina NS, Burshtein EA. Fluorescence of tryptophan residues of serum albumin. Mol Biol (Mosk) 1971; 5:214-24.
31. Nyamaa D, Bat-Erdene O, Burshtein EA. The effect of media on the functional and structural properties of serum albumins: II The effect of temperature on the N-form of human serum albumin. Mol Biol (Mosk) 1984;18:972-8.
32. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 1992;358:209-15.
33. Takeda K, Wada A, Yamamoto K, Moriyama Y, Aoki K. Conformational changes of bovine serum albumin by heat treatment. J Protein Chem 1989;8:653-9.
34. Takeda K, Yoshida I, Yamamoto K. Changes of fluorescence lifetime and rotation correlation time of bovine serum albumin labeled with 1-dimethyl-aminonaphtalene-5-sulfonyl chloride in guanidine and thermal denaturations. J Protein Chem 1991;10:17-23.
35. Janssen LHM, Droge JHM, Durlinger FCJ, Fruytier FJ. The pH dependence of the thermodynamics of the interaction of diazepam with human serum albumin. J Biol Chem 1985;260: 11442-5.
36. Aki H, Yamamoto M. Thermodynamic aspects of fatty acids binding to human serum albumin: A microcalorimetric investigation. Chem Pharm Bull 1992;40:553-8.
37. Kragh-Hansen U. Structure and ligand binding properties of human serum albumin. Dan Med Bull 1990;37:57-84.
38. Herve F, Urien S, Albengres E, Duche JC, Tillement JP. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clin Pharmacokinet 1994;26: 44-58.
39. Kalousek I, Jandova D, Vodrazka Z. The binding curves in relation to protein concentration. The interaction of human serum albumin with phthalein dyes and azo dyes. Int J Biochem 1984;16:121-3.
40. Reynolds JA, Herbert S, Polet H, Steinhardt J. The binding of diverse detergent-anions to bovine serum albumin. Biochemistry 1967;6:937-7.
41. Honore B. Conformational changes in human serum albumin induced by ligand binding. Pharmacol Toxicol 1990;66(Suppl. 2):1-26.
42. Dengler TJ, Roberte-Vaupel GM, Dengler HJ. Albumin binding in uraemia. Quantitative assessement of inhibition by endogenous ligands and carbamylation of albumin. Eur J Clin Pharm 1992;43:491-9.